Life sciences partner Marc Rubenstein and associates Kyle Connors and Mallory Ursul authored a 2022 Chambers Global Practice Guide chapter on “Life Sciences U.S. Trends and Developments.”
The authors note the COVID-19 pandemic has had a profound impact on the life sciences industry giving rise to a surge in collaborations, increased adoption in decentralized clinical trials and a shift towards supplier diversification. Many life sciences companies are more collaborative, more digital and more focused on pandemic preparedness than they would have been without the pandemic. As the pandemic turns endemic and new variants emerge, emerging trends and developments in the biotechnology, pharmaceutical, medical device and digital health sectors for the year ahead are examined in the article.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.